Scynor Pharmaceuticals Private Limited

Scynor Pharmaceuticals Private Limited - chemicals in Raisen, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U24239MP2021PTC054905 Incorporated 12 February 2021 ROC Gwalior HQ Raisen, Madhya Pradesh, India
Active Private Limited Company chemicals Startup India MSME · Micro
Data last updated
Revenue · FY 2024
₹32.2 Lakh
▲ 122% YoY
Net profit · FY 2024
₹1.91 Lakh
Net margin 5.9%
EBITDA · FY 2024
₹2.68 Lakh
EBITDA margin 8.3%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Scynor Pharmaceuticals Private Limited

Data last updated:

Scynor Pharmaceuticals Private Limited is a private limited company based in Raisen, Madhya Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 12 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2021PTC054905.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Deepak Kumar Tiwari and Phul Kumari Tiwari.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 215 Sheetal Mega City Phase 2 Dahod Road Mandideep, Raisen, Madhya Pradesh, India – 462046.

As per the financials filed for FY 2024, the company reported a revenue of ₹32.2 Lakh, a growth of 122% compared to the previous year. For the same year it recorded a net profit of ₹1.91 Lakh (net margin 5.9%) and EBITDA of ₹2.68 Lakh (EBITDA margin 8.3%).

Scynor Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-35-0002557).

Company details

CIN U24239MP2021PTC054905
Registration Number 054905
Incorporation Date 12 February 2021
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MP-35-0002557

Recognitions & Rankings of Scynor Pharmaceuticals

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2021-22)
Udyam number
UDYAM-MP-35-0002557

Contact details

Scynor Pharmaceuticals Private Limited's registered office is in Raisen, Madhya Pradesh.

  • Registered Address
    215 Sheetal Mega City Phase 2 Dahod Road Mandideep, Raisen, Madhya Pradesh, India – 462046
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Scynor Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Scynor Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Scynor Pharmaceuticals Private Limited, buy the company report.

Financials of Scynor Pharmaceuticals Private Limited

FY 2025 filings available

Scynor Pharmaceuticals Private Limited reported revenue of ₹32.2 Lakh (up 122% YoY) for FY 2024.

Revenue · FY 2024
₹32.2 Lakh ▲ 122%
Net profit · FY 2024
₹1.91 Lakh margin 5.9%
EBITDA · FY 2024
₹2.68 Lakh margin 8.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 122%
EBITDA CAGR growth
1 year
▲ 268%

Revenue rose 122% in the latest year. EBITDA rose 268% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.68 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.91 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8.3%
Net Profit Margin5.9%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Scynor Pharmaceuticals Private Limited, buy the company report.

Board of directors of Scynor Pharmaceuticals Private Limited

Scynor Pharmaceuticals has 3 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Deepak Kumar TiwariDirector12 Feb 20215 Years 8 MonthsCurrent
Phul Kumari TiwariDirector12 Feb 20215 Years 8 MonthsCurrent
Savita TiwariDirector12 Feb 20215 Years 8 MonthsCurrent

Peer comparison

Scynor Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Nano Pharmaceuticals Private Limited₹32.34 Lakh (FY 2024)6.0%Indore, Madhya Pradesh, India
Shinevet Pharmaceuticals Private Limited₹32.29 Lakh (FY 2025)51.0%Gorakhpur, Uttar Pradesh, India
Scynor Pharmaceuticals Private Limitedthis company₹32.2 Lakh (FY 2024)₹1.91 Lakh5.9%122.0%Raisen, Madhya Pradesh, India
Forton Pharmaceuticals Private Limited₹32.12 Lakh (FY 2019)4.0%Pune, Maharashtra, India
Soleil Pharmaceuticals Private Limited₹32.1 Lakh (FY 2025)-22.0%Chennai, Tamil Nadu, India
Moonlight Pharmaceuticals Private Limited₹32.07 Lakh (FY 2017)16.0%Sri Ganganagar, Rajasthan, India

To see the full peer comparison of Scynor Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Scynor Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Scynor Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Scynor Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Deepak Kumar Tiwari was appointed as Director on 12 Feb 2021.

AGM
Scynor Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Scynor Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Deepak Kumar Tiwari was appointed as Director.
Appointed
Phul Kumari Tiwari was appointed as Director.
Appointed
Savita Tiwari was appointed as Director.
Incorporation
12 Feb 2021
Scynor Pharmaceuticals Private Limited was registered on 12 Feb 2021 with Roc Gwalior & aged 5 years 8 months as per MCA records.

Frequently asked questions

Scynor Pharmaceuticals is an active private limited company based in Raisen, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 12 February 2021 (5+ years old) and is registered under CIN U24239MP2021PTC054905.

Scynor Pharmaceuticals has 3 current directors:

The latest financial statements of Scynor Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Scynor Pharmaceuticals is U24239MP2021PTC054905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Scynor Pharmaceuticals was incorporated on 12 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.

The peers of Scynor Pharmaceuticals by revenue are Nano Pharmaceuticals Private Limited, Shinevet Pharmaceuticals Private Limited, Forton Pharmaceuticals Private Limited, Soleil Pharmaceuticals Private Limited, Moonlight Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).

Deepak Kumar Tiwari was appointed as Director on 12 Feb 2021. Phul Kumari Tiwari was appointed as Director on 12 Feb 2021. Savita Tiwari was appointed as Director on 12 Feb 2021.

Yes, Scynor Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Scynor Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-35-0002557).

The registered office of Scynor Pharmaceuticals is at 215 Sheetal Mega City Phase 2 Dahod Road Mandideep, Raisen, Madhya Pradesh, India – 462046.

Scynor Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.